What is the next best step in managing an elderly patient with a chronic cough unresponsive to doxycycline and steroids?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Chronic Cough Unresponsive to Doxycycline and Steroids in an Elderly Patient

The next best step is to obtain a chest CT scan to evaluate for underlying structural pathology, malignancy, or interstitial lung disease, followed by systematic evaluation and treatment for the most common causes: upper airway cough syndrome (UACS), asthma/non-asthmatic eosinophilic bronchitis (NAEB), and gastroesophageal reflux disease (GERD). 1

Critical Initial Considerations

Imaging and Diagnostic Workup

  • Chest radiograph and spirometry are mandatory in all patients with chronic cough (>8 weeks duration). 1
  • If the chest X-ray shows abnormalities suggestive of malignancy, interstitial disease, or infection, chest CT followed by bronchoscopy or transthoracic fine-needle aspiration should be the immediate next step. 1 This is particularly important in elderly patients where malignancy risk is elevated.
  • High-resolution CT (HRCT) may be valuable when other targeted investigations are normal, especially to evaluate for interstitial lung disease or bronchiectasis. 1

Medication Review

  • If the patient is on an ACE inhibitor, it must be stopped immediately regardless of temporal relationship to cough onset, as ACE inhibitor-induced cough can persist and the original cause may have resolved. 1 Cough typically resolves within days to 2 weeks (median 26 days) after discontinuation. 1

Systematic Algorithmic Approach

Step 1: Evaluate and Treat Upper Airway Cough Syndrome (UACS)

  • Begin with a first-generation antihistamine-decongestant (A/D) combination as initial empiric therapy, as UACS is the most common cause of chronic cough. 1
  • Response typically occurs within days to 1-2 weeks, though complete resolution may take several weeks to months. 1
  • If partial response occurs with persistent nasal symptoms, add topical nasal corticosteroid, nasal anticholinergic, or nasal antihistamine. 1
  • If symptoms persist, obtain sinus imaging (CT or plain films) to evaluate for acute or chronic sinusitis. 1
  • Treat documented sinusitis with antibiotics and short-term nasal vasoconstrictor therapy. 1

Step 2: Evaluate and Treat Asthma or NAEB

Since the patient already received steroids without improvement, this requires careful reconsideration:

  • Bronchial provocation testing (methacholine challenge) should be performed if spirometry is normal to definitively evaluate for asthma. 1, 2
  • A negative bronchial provocation test excludes asthma but does not rule out steroid-responsive cough. 1
  • Induced sputum for eosinophil count should be obtained to distinguish NAEB from other causes. 1, 2
  • Fractional exhaled nitric oxide (FENO) can assess eosinophilic inflammation and predict corticosteroid responsiveness. 2

Treatment approach if asthma/NAEB is confirmed:

  • Inhaled corticosteroids (ICS) are first-line treatment (equivalent to beclomethasone 200-800 μg daily), not systemic steroids. 1, 2 The previous oral steroid trial may have been inadequate in dose, duration, or delivery method.
  • If response is incomplete after 4-8 weeks, increase ICS dose up to 2000 μg beclomethasone equivalent daily. 1, 2
  • Add a leukotriene receptor antagonist (montelukast) if ICS alone is insufficient. 1, 2
  • Consider adding long-acting beta-agonists in combination with ICS. 1

Important caveat: If there was no response to a 2-week oral steroid trial, cough is unlikely due to eosinophilic airway inflammation. 1 However, the lack of response to previous steroids in this case may reflect inadequate treatment of other coexisting causes rather than absence of asthma/NAEB. 1

Step 3: Evaluate and Treat GERD

  • GERD is a commonly missed cause of treatment failure and can occur without gastrointestinal symptoms. 1
  • Intensive acid suppression with proton pump inhibitors (PPIs) and alginates should be undertaken for a minimum of 3 months. 1
  • Empirical treatment should be offered before oesophageal testing, as no current test of esophageal function reliably predicts treatment response. 1
  • GERD commonly coexists with asthma and UACS, and cough will not resolve until all contributing factors are treated. 1, 2

Critical Understanding: Multifactorial Nature

Chronic cough is frequently multifactorial—patients commonly have two or all three of UACS, asthma, and GERD simultaneously. 1 The cough will not resolve until all contributing causes are effectively treated. 1 Therapy should be given in sequential and additive steps rather than stopping one treatment when starting another. 1

When to Refer

Referral to a specialist cough clinic is indicated when:

  • Cough remains undiagnosed after systematic evaluation of UACS, asthma/NAEB, and GERD. 1
  • There is no response to appropriate empiric trials of treatment. 1
  • Chest imaging reveals concerning findings requiring subspecialty evaluation. 1

Common Pitfalls to Avoid

  • Failing to recognize that the previous doxycycline trial was likely inappropriate unless there was documented bacterial sinusitis or COPD exacerbation. 1, 3 Antibiotics have no role in most chronic cough cases.
  • Assuming oral steroids adequately treated asthma/NAEB—inhaled corticosteroids with proper technique are required for sustained benefit. 1, 2, 4
  • Not treating GERD empirically even in the absence of reflux symptoms, as this is a frequent cause of treatment failure. 1
  • Stopping one treatment when starting another rather than using additive sequential therapy. 1
  • Not considering malignancy or tuberculosis in elderly patients, especially those from endemic areas or with systemic symptoms. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Cough Variant Asthma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.